Here, we examine the perspective of triple helix actors (i.e., those in academia, government, and industry) related to the availability of human and financial capital in select Central European ecosystems. The actors perceive the lack of venture capital to be the top reason hindering the development of the biopharmaceutical industry in their region. The human capital area with the greatest shortage was the computational sciences/informatics. This was followed by clinical trials and regulatory affairs. The present paper should be of interest to scholars and those engaged in the biopharmaceutical industry and regional development.

中文翻译：

---

Triple helices 对部分中欧生态系统生物制药创新人力和金融资本可用性的看法

在这里，我们研究了与选定中欧生态系统中人力和金融资本可用性相关的三螺旋参与者（即学术界、政府和工业界的参与者）的观点。参与者认为缺乏风险投资是阻碍其所在地区生物制药行业发展的首要原因。最短缺的人力资本领域是计算科学/信息学。其次是临床试验和监管事务。本文应引起学者和从事生物制药产业和区域发展的人士的兴趣。